These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1190919)

  • 1. Cardiovascular and antiarrhythmic effects of carnitine.
    DiPalma JR; Ritchie DM; McMichael RF
    Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):246-50. PubMed ID: 1190919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the antiarrhythmic action of ajmaline, N-n-propylajmalinehydrogen-tartrate and 4-[3'-diethylamino-2'-hydroxypropyl]-ajmalinehydrogentartrate (Tachmalcor) with their hemodynamic and cardiac side-effects].
    Femmer K; Grünheid K
    Pharmazie; 1976; 31(1):33-6. PubMed ID: 1257276
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodynamics before and after conversion of atrial fibrillation to normal sinus rhythm in horses.
    Muir WW; McGuirk SM
    J Am Vet Med Assoc; 1984 Apr; 184(8):965-70. PubMed ID: 6715228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs.
    Frederick LG; Hatley FR; McDonald SJ; Stamm MH; Garthwaite SM
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic circulatory effects of pentagastrin.
    Pawlik WW; Gustaw P; Czarnobilski K; Konturek SJ
    Acta Physiol Pol; 1987; 38(5):418-24. PubMed ID: 3452974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
    Diederich KW; Boyksen D
    Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans.
    Kochiadakis GE; Skalidis EI; Kalebubas MD; Igoumenidis NE; Chrysostomakis SI; Kanoupakis EM; Simantirakis EN; Vardas PE
    Eur Heart J; 2002 May; 23(9):734-41. PubMed ID: 11978000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiarrhythmic, cardiovascular and toxic actions of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethlenediamine (Falirytmin) as compared to propranolol, quinidine and ajmaline].
    Terhaag B; Förster W
    Pharmazie; 1976; 31(9):635-9. PubMed ID: 1019213
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic and metabolic activities of propionyl-L-carnitine in rats with pressure-overload cardiac hypertrophy.
    Yang XP; Samaja M; English E; Benatti P; Tarantola M; Cardace G; Motterlini R; Micheletti R; Bianchi G
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):88-98. PubMed ID: 1383636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the antiarrhythmic activity of quinidine and quinine.
    Klevans LR; Kelly RJ; Kovacs JL
    Arch Int Pharmacodyn Ther; 1977 May; 227(1):57-68. PubMed ID: 901074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional role of alpha-calcitonin gene-related peptide in the regulation of the cardiovascular system.
    Shen YT; Pittman TJ; Buie PS; Bolduc DL; Kane SA; Koblan KS; Gould RJ; Lynch JJ
    J Pharmacol Exp Ther; 2001 Aug; 298(2):551-8. PubMed ID: 11454916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Kosior DA; Kochanowski J; Scisło P; Piatkowski R; Postuła M; Rabczenko D; Opolski G
    Cardiol J; 2009; 16(6):521-7. PubMed ID: 19950088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.
    Kniffen FJ; Winokur S; Counsell RE; Lucchesi BR
    J Pharmacol Exp Ther; 1976 Feb; 196(2):420-32. PubMed ID: 3643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of some antiarrhythmic drugs on systolic time intervals in normal subjects (author's transl)].
    Breithardt G; Jochum E; Kuhn H; Seipel L
    Z Kardiol; 1978 Oct; 67(10):6,0-7. PubMed ID: 366939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiarrhythmic, cardiovascular and toxic effects of 4-[3'-diethylamino-2'-hydroxypropyl]-ajmaline (Tachmalcor) in comparison with ajmaline and propranolol].
    Terhaag B; Förster W; Mest HJ; Schrör K
    Pharmazie; 1976; 31(1):39-44. PubMed ID: 1257278
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between hemodynamic changes and endogenous catecholamine release caused by a new antiarrhythmic agent, AB-2, in cats and dogs.
    Filczewski M; Oledzka K; Szymańska-Kosmala M
    Pol J Pharmacol Pharm; 1982; 34(5-6):287-94. PubMed ID: 7187044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The differentiated therapy of paroxysms of atrial fibrillation and flutter in patients with ischemic heart disease in relation to the duration of the arrhythmia before the start of treatment].
    Shabrov AV; Olesin AI; Golub IaV; Smolin ZIu
    Ter Arkh; 1998; 70(8):25-9. PubMed ID: 9770739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heart and circulatory effects of quinidine stereoisomers].
    Reuter N; Meyer F
    Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):152-63. PubMed ID: 1015910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACTH and alpha-MSH: cardiovascular and antiarrhythmic properties.
    Lindner E; Schölkens B
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):19-23. PubMed ID: 4367710
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular effects of 5-hydroxypropranolol (ORF 12592) in dogs.
    Ram N; Bauer EW; Hesse UC; Heilman RD
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):118-25. PubMed ID: 921395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.